SidaSubSaharaV1, Ncbi, Checkpoint, bibRecord, 000B71

Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings

Identifieur interne : 000B71 ( Ncbi/Checkpoint ); précédent : 000B70; suivant : 000B72

Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings

Auteurs : David Vlahov [États-Unis] ; Angela M. Robertson ; Steffanie A. Strathdee

Source :

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [ 1058-4838 ] ; 2010.

RBID : PMC:3114556

Descripteurs français

KwdFr :
- Contrôle des maladies contagieuses (), Humains, Infections à VIH (), Infections à VIH (transmission), Infections à VIH (épidémiologie), Toxicomanie intraveineuse (), Usagers de drogues.
MESH :
- épidémiologie : Infections à VIH.
- Contrôle des maladies contagieuses, Humains, Infections à VIH, Toxicomanie intraveineuse, Usagers de drogues.

English descriptors

KwdEn :
- Communicable Disease Control (methods), Drug Users, HIV Infections (epidemiology), HIV Infections (prevention & control), HIV Infections (transmission), Humans, Substance Abuse, Intravenous (complications).
MESH :
- complications : Substance Abuse, Intravenous.
- epidemiology : HIV Infections.
- methods : Communicable Disease Control.
- prevention & control : HIV Infections.
- transmission : HIV Infections.
- Drug Users, Humans.

Abstract

Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of ~16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub- Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (i.e., methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114556

DOI: 10.1086/651482
PubMed: 20397939
PubMed Central: 3114556

Affiliations:

Links to Exploration step

PMC:3114556

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings</title>
<author><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, New York</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea> Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2"> Joseph L. Mailman School of Public Health, Columbia University, New York, New York</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea> Joseph L. Mailman School of Public Health, Columbia University, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
<affiliation><nlm:aff id="A3"> Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla</nlm:aff>
<wicri:noCountry code="subfield">La Jolla</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
<affiliation><nlm:aff id="A3"> Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla</nlm:aff>
<wicri:noCountry code="subfield">La Jolla</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20397939</idno>
<idno type="pmc">3114556</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114556</idno>
<idno type="RBID">PMC:3114556</idno>
<idno type="doi">10.1086/651482</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">001211</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001211</idno>
<idno type="wicri:Area/Pmc/Curation">001210</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001210</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002470</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002470</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">000417</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000417</idno>
<idno type="wicri:Area/PubMed/Curation">000417</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000417</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000417</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000417</idno>
<idno type="wicri:Area/Ncbi/Merge">000B71</idno>
<idno type="wicri:Area/Ncbi/Curation">000B71</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B71</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings</title>
<author><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, New York</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea> Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2"> Joseph L. Mailman School of Public Health, Columbia University, New York, New York</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea> Joseph L. Mailman School of Public Health, Columbia University, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
<affiliation><nlm:aff id="A3"> Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla</nlm:aff>
<wicri:noCountry code="subfield">La Jolla</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
<affiliation><nlm:aff id="A3"> Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla</nlm:aff>
<wicri:noCountry code="subfield">La Jolla</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</title>
<idno type="ISSN">1058-4838</idno>
<idno type="eISSN">1537-6591</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Communicable Disease Control (methods)</term>
<term>Drug Users</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (prevention & control)</term>
<term>HIV Infections (transmission)</term>
<term>Humans</term>
<term>Substance Abuse, Intravenous (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Contrôle des maladies contagieuses ()</term>
<term>Humains</term>
<term>Infections à VIH ()</term>
<term>Infections à VIH (transmission)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Toxicomanie intraveineuse ()</term>
<term>Usagers de drogues</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance Abuse, Intravenous</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Users</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Contrôle des maladies contagieuses</term>
<term>Humains</term>
<term>Infections à VIH</term>
<term>Toxicomanie intraveineuse</term>
<term>Usagers de drogues</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of ~16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub- Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (i.e., methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>État de New York</li>
</region>
</list>
<tree><noCountry><name sortKey="Robertson, Angela M" sort="Robertson, Angela M" uniqKey="Robertson A" first="Angela M." last="Robertson">Angela M. Robertson</name>
<name sortKey="Strathdee, Steffanie A" sort="Strathdee, Steffanie A" uniqKey="Strathdee S" first="Steffanie A." last="Strathdee">Steffanie A. Strathdee</name>
</noCountry>
<country name="États-Unis"><region name="État de New York"><name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
</region>
<name sortKey="Vlahov, David" sort="Vlahov, David" uniqKey="Vlahov D" first="David" last="Vlahov">David Vlahov</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B71 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000B71 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     PMC:3114556
   |texte=   Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:20397939" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings

Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.